OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Discovery of Novel ERα and Aromatase Dual-Targeting PROTAC Degraders to Overcome Endocrine-Resistant Breast Cancer
Lilan Xin, Chao Wang, Yan Cheng, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 11, pp. 8913-8931
Closed Access | Times Cited: 8
Lilan Xin, Chao Wang, Yan Cheng, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 11, pp. 8913-8931
Closed Access | Times Cited: 8
Showing 8 citing articles:
(E)-1-(3-(3-Hydroxy-4-Methoxyphenyl)-1-(3,4,5-Trimethoxyphenyl)allyl)-1H-1,2,4-Triazole and Related Compounds: Their Synthesis and Biological Evaluation as Novel Antimitotic Agents Targeting Breast Cancer
Gloria Ana, Azizah M. Malebari, Sara Noorani, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 118-118
Open Access
Gloria Ana, Azizah M. Malebari, Sara Noorani, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 118-118
Open Access
Novel dual-targeting PROTAC degraders of GSK-3β and CDK5: A promising approach for pancreatic cancer treatment
Neerasa Jayaprakash, Byeonggwan Kim, Hye Jin Chung
Bioorganic & Medicinal Chemistry (2025) Vol. 120, pp. 118085-118085
Closed Access
Neerasa Jayaprakash, Byeonggwan Kim, Hye Jin Chung
Bioorganic & Medicinal Chemistry (2025) Vol. 120, pp. 118085-118085
Closed Access
Applications of Bridgehead Heterocycles in Drug Design and Medicinal Chemistry
Simona Di Martino, Pietro Amico, Maria De Rosa
Topics in Current Chemistry (2025) Vol. 383, Iss. 2
Closed Access
Simona Di Martino, Pietro Amico, Maria De Rosa
Topics in Current Chemistry (2025) Vol. 383, Iss. 2
Closed Access
Recent advances in dual PROTACs degrader strategies for disease treatment
Jianyu Liu, Yanzhuo Liu, Jiao Tang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116901-116901
Closed Access | Times Cited: 2
Jianyu Liu, Yanzhuo Liu, Jiao Tang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116901-116901
Closed Access | Times Cited: 2
MicroRNA‐Triggered Programmable DNA‐Encoded Pre‐PROTACs for Cell‐Selective and Controlled Protein Degradation
Jiayin Zhan, Xiang Li, Zhe Feng, et al.
Angewandte Chemie International Edition (2024)
Closed Access | Times Cited: 1
Jiayin Zhan, Xiang Li, Zhe Feng, et al.
Angewandte Chemie International Edition (2024)
Closed Access | Times Cited: 1
MicroRNA‐Triggered Programmable DNA‐Encoded Pre‐PROTACs for Cell‐Selective and Controlled Protein Degradation
Jiayin Zhan, Xiang Li, Zhe Chuan Feng, et al.
Angewandte Chemie (2024)
Closed Access
Jiayin Zhan, Xiang Li, Zhe Chuan Feng, et al.
Angewandte Chemie (2024)
Closed Access
In Silico Design of Dual Estrogen Receptor and Hsp90 Inhibitors for ER-Positive Breast Cancer Through a Mixed Ligand/Structure-Based Approach
Gabriele La Monica, Federica Alamia, Alessia Bono, et al.
Molecules (2024) Vol. 29, Iss. 24, pp. 6040-6040
Open Access
Gabriele La Monica, Federica Alamia, Alessia Bono, et al.
Molecules (2024) Vol. 29, Iss. 24, pp. 6040-6040
Open Access
Development of PROTACs targeting estrogen receptor: An emerging technique for combating endocrine resistance
Rouming Peng, Xin Liu, Chun‐Chi Chen, et al.
RSC Medicinal Chemistry (2024)
Closed Access
Rouming Peng, Xin Liu, Chun‐Chi Chen, et al.
RSC Medicinal Chemistry (2024)
Closed Access
